Market Research Blog – Page 14433 – New Product Development

Ethylene Dichloride Market is expected to register 3.7% CAGR between 2022 and 2028

Future Market Insights has published a new research study titled “Ethylene Dichloride Market: Global Industry Analysis 2013–2021 and Opportunity Assessment 2022–2028”. As per data cited in the report, the market value roughly equated US$ 19.2 Bn in 2022, which will reportedly grow at a modest 3.7% CAGR through 2028. The overall Y-o-Y growth estimated for the global ethylene dichloride market will remain moderate, under-4% throughout the projection period, 2022-2028.

The study attributes the positive growth prospects of ethylene dichloride market to the increasing consumption of ethylene dichloride (EDC) across the chemical industry, which is further strongly supported by robust growth of infrastructural activities demanding volumes of ethylene dichloride for specialized applications. According to FMI’s analysis, applications of ethylene dichloride will be prominent in polyvinyl chloride (PVC) or vinyl monomer chloride, generating high traction within the residential and commercial infrastructure.

Vinyl monomer chloride segment is estimated to hold more than a three-fourths market value share in the global market by the end of the forecast period.
Collectively, North America and East Asia are expected to hold more than half the value share of the global ethylene dichloride market.
In the East region, China is a prominent consumer of ethylene dichloride.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-351

Chemical Industry Continues to Extend the Lion’s Share towards Ethylene Dichloride Market Growth

The global chemical industry is expected to exhibit strong growth over the next few decades, which is most likely to accelerate a shift from imports to domestic manufacturing bases, particularly in emerging economies. While developing regional markets continue to receive strong governmental support, the report opines that consumption of ethylene dichloride will continue to see a surge over the coming years.

Substantial volumes of ethylene dichloride are consumed as a solvent in the manufacturing of ethylene amines and in the fumigation production process. Thus, the growth of the chemical industry is expected to directly propel the growth of ethylene dichloride market.

Furthermore, growth of textile, adhesives, and mining industries will create high-potential opportunities for intermediates such as ethylene dichloride. Such organic growth across multiple end users of ethylene dichloride is projected to fuel the global ethylene dichloride market growth during the forecast period.

Ethylene Dichloride Finds Applications as a Raw Material in PVC Production

Ethylene dichloride is predominantly used as a raw material of polyvinyl dichloride (PVC) and thus, the ethylene dichloride market is influenced by the thriving PVC/VCM market.

Global PVC sales accounted for the revenue of over US$ 58 billion in 2017 and the consumption is expected to grow at a healthy rate through 2022, as indicated by research. In light of this unmet demand for PVC, the global ethylene dichloride market is anticipated to register a healthy CAGR throughout the forecast period.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-351

Stringent Regulations on Ethylene Dichloride Create Manufacturing Challenges

On the flip side, ethylene dichloride is toxic in nature and highly flammable, and has a pleasant chloroform-like odour and irritating vapours. It can affect the nervous system, cause nausea, drunkenness, depression, and vomiting.

EDC affects the central nervous system and cardiovascular system and in certain cases, it may be fatal. It is considered poison for the liver and kidney. These factors are estimated to hinder the overall performance of ethylene dichloride market in years to come.

Leading Ethylene Dichloride Manufacturers Adopt Application-specific Business Strategies

Key players of the global ethylene dichloride market are focusing on collaborations, innovative product development, acquisitions, and expansion. Manufacturers are primarily targeting high development areas and producing application-specific products to gain higher market attraction.

Olin Corporation (Manufacture of ethylene dichloride) signed an agreement with The NRC Group for the distribution of chemical products including ethylene dichloride, epoxy resins and curing agents for coatings, civil engineering, adhesives and composites industries across Europe. Further, in 2015, the company acquired the Chloralkali and epoxy division from The Dow Chemical Company to fulfil the increasing demand for commodity chemicals.
Three subsidiaries of TOSOH CORPORATION, a manufacturer of ethylene dichloride, namely Tosoh Finechem Corporation, Tosoh F-Tech, Inc and Tosoh Organic Chemical Co., Ltd. were merged together to combine their distinctive technologies to accelerate the development of chemical compounds.
In 2019, Formosa Plastics Corporation, a manufacturer of ethylene dichloride, announced the expansion of ethylene dichloride production by up to 800,000 metric tons per annum in Mailiao, Taiwan.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-351

The report on the global ethylene dichloride market studies some of the major players in the ethylene dichloride market, such as Occidental Chemical Corporation, Formosa Plastic Corporation, Olin Corporation, Vynova Group, Tosoh Corporation, SABIC, Tokyo Chemical Industry Co., Ltd. PT Asahimas Chemical, Prochem, Inc., and ThyssenKrupp AG, and among others.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Corporate Headquarter
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Website: https://www.futuremarketinsights.com

Graphene Nanocomposites Market reaching a valuation of US$ 2,796.7 Mn by 2031

The global graphene nanocomposites market value worth US$ 167.5 Mn in 2021. Increasing application in the electronics sector for devices and semiconductors is expected to propel sales at 32.5% CAGR, with the market valuation reaching US$ 2,796.7 Mn in 2031.

Rising demand for graphene nanocomposites for applications in medicine, water treatment, research, aerospace, polymer composites, electronics and optics is boosting sales in the market. Besides this, increasing adoption of innovative techniques to commercialize graphene nanocomposites is also boding well for the market.

Consumer preference for graphene oxide for various end uses like cellular imaging, drug delivery, and cancer treatment, is creating lucrative growth prospects for graphene nanocomposites market players.

As per FMI’s regional analysis, the U.S. is anticipated to dominate the global graphene nanocomposites market. Growth can be attributed to the presence of leading players such as Angstron Materials, Inc., along with the country being a top player in medical research and the bio-medical sector.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-3154

“Increasing demand for graphene oxide nanocomposites in the paints & coatings industry, along with expansion of the electronics sector in emerging economies will continue pushing sales in the market over the assessment period,” says the FMI analyst.

Key Takeaways:

By product type, sales in the graphene oxide segment are expected to increase at a 31.3% CAGR over the forecast period.

Demand for graphene nanocomposites in the electronics industry is anticipated to create an incremental opportunity of US$ 597.7 Mn over the assessment period.

The U.S. is anticipated to hold a dominant share of 87.2% of the North America graphene nanocomposites market by 2031.

China will emerge as a lucrative market, creating an incremental opportunity of US$ 623.8 Mn in 2031.

Germany is projected to account for 22.0% of the Europe graphene nanocomposites market share in 2031.

South Korea and Russia will hold 10.3% and 4.1% of the global graphene nanocomposites market share respectively in 2021.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-3154

Competitive Landscape

Versarien Plc, Haydale Graphene Industries Plc, Graphenea S.A, XG Sciences Inc., Applied Graphene Materials PLC, Taiwan Graphene Co., Ltd., and others are some players operating in the graphene nanocomposites market profiled by FMI.

Leading players operating in the graphene nanocomposites market are investing in strategic business agreements for commercialization of graphene and are focusing on incorporation of proprietary and green technology for graphene production. Apart from this, players are focusing on research and development to explore new application areas of graphene nanocomposites that can serve more end uses to gain a competitive edge. For instance:

In March 2021, First Graphene Ltd collaborated with Gerdau S.A. to develop the market for PureGRAPH graphene products, which are graphene platelets that enhance the performance of cement composites, in the Americas.

More Insights into the Graphene Nanocomposites Market Report

In its latest report, FMI offers an unbiased analysis of the global graphene nanocomposites market, providing historical data for the period of 2018-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (graphene oxide and graphene nano platelets), and application (electronics, energy storage, automotive and aerospace, polymer composites, medical and bio-medical, water treatment, and research and development) across four regions (North America, Europe, East Asia, and Rest of World).

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-3154

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Residential & Commercial Smart Glass Market | Residential End-user Segment is Projected to Lead in Global Industry

Residential and commercial smart glass worth approximately US$ 15 billion will be sold by the end of 2028. Up from the market value attained in 2018, the global sales of residential and commercial smart glass are estimated to observe a substantial CAGR of over 15% during 2018-2028.

According to a new market study of Future Market Insights, the demand for residential and commercial smart glass will remain on a constant high over the coming years. The global residential and commercial smart glass market is currently receiving strong demand from the commercial sector. However, it is more likely that the demand for smart glass will gather momentum in the residential sector, in the near future. The report attributes this demand growth to increasing initial interest of buyers in residential and commercial smart glass, particularly for bungalows and luxury apartments.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-473

Energy Control & Other Clean Technology Initiatives to Boost Residential & Commercial Smart Glass Market Growth

Various initiatives for the clean technology and mostly related to energy conservation and sustainable use of energy is driving the customers to use different products which would serve the purpose. Also, these initiatives are compelling manufacturers of residential and commercial smart glass to invest heavily in the development of versatile products compatible for efficient energy consumption, besides basic functionalities of smart glass.

On the other side, residential and commercial smart glass solutions incur heavy initial expenditure that includes procurement as well as installation expenses. High procurement and maintenance expenses will remain longstanding challenges associated with the revenue growth of residential and commercial smart glass market. Moreover, though most residential and commercial smart glass solutions are dirt-proof and demand occasional cleaning, regular maintenance is required to keep these integrated technologies bug-proof, which further demands expensive regular maintenance. This is projected to have a restraining impact on the overall adoption rate of residential and commercial smart glass solutions.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-473

Global Residential and Commercial Smart Glass Market Forecast

As far as the residential and commercial smart glass market is observed for indoor conference room, office privacy protection, shower room and product projection application, switchable PDLC (Polymer dispersed liquid crystals) residential and commercial smart glass are used the most.

By region, North America is anticipated to dominate the global residential and commercial smart glass market over the forecast period. North America residential and commercial smart glass market, is expected to be followed by Europe residential and commercial smart glass due to the high percentage of luxurious homes and other commercial building in the region.

In terms of growth rate SEA & others of APAC has the highest CAGR in the residential and commercial smart glass market, followed by China and Latin America residential and commercial smart glass market, which also have a good growth rate compared to the other regions in the market.

The market for the residential and commercial smart glass market is segmented on the basis of end-user, technology type and regions. The end–user segment in the residential and commercial smart glass market is further divided into residential and commercial segments. The residential segment is then further divided into smart windows & doors, smart glass partitions, smart shower glass, and smart glass walls. The commercial sector is further segmented into commercial buildings, architectural use, automobiles, aircraft, marine, consumer electronics and others.

As per the technology type segment the residential and commercial smart glass market is segmented into Electrochromic, Thermochromic, Photochromic, Suspended Particle Device, and Liquid Crystal. The residential and commercial smart glass market is also divided as per building type in the residential segment.

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-473

Residential and Commercial Smart Glass Market: Segmentation

On the basis of end user, the global residential and commercial smart glass market has been segmented into:

Residential
Commercial

On the basis of technology type, the global residential and commercial smart glass market has been segmented into:

Electrochromic
Thermochromic
Photochromic
Suspended Particle Device
Liquid Crystal

About Future Market Insights (FMI)

Colloidal Metal Particles Market is expected to grow at a robust 8.1% CAGR between 2022 and 2028

FMI presents an in-depth analysis and key insights on the global colloidal metal particles market in its latest market study titled ‘Colloidal Metal Particles Market: Global Industry Analysis 2013 – 2021 and Opportunity Assessment 2022 – 2028’. The long-term outlook on the global colloidal metal particles market remains positive with the market valued at over US$ 20.2 Bn by 2022 end and expected to reach US$ 32.3 Bn by 2028 end. The global colloidal metal particles market is estimated to expand at a growth rate of over 8.1%, through the forecast period.

Among the product type segments, the titanium oxide colloidal metal particles segment is expected to account for a large volume proportion of the market while the gold colloidal metal particles segment, given its high price, is expected to account for a noteworthy value proportion in the in the colloidal metal particles market during the forecast period.

From a regional viewpoint, China is anticipated to hold a sizeable proportion of the market throughout the forecast period, witnessing 7.6% growth between 2022 and 2028. In its latest offering, FMI shares key insights on drivers, restraints and trends likely to impact the colloidal metal particles market during this period.

Get a Free Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9012

Rising Use of Colloidal Metal Particles as Catalysts to Propel the Growth of Global Colloidal Metal Particles Market

Future Market Insights suggests that the global colloidal metal particles market is estimated to register robust growth throughout the forecast period, prominently due to its rising applications as a catalyst. The chemical industry has been making a shift towards nano scaled catalysts, a move that will prove to be beneficial for the colloidal metal particles market.

The enhanced surface area per particle escalates the efficiency of the catalyst, an important factor responsible for increasing the demand for colloidal metal particles within the chemical industry. Colloidal metal particles are also being increasingly used in dietary supplements, either directly or in combination with other ingredients. For instance, copper colloid metal particles are increasingly being used to enhance the human body’s ability to absorb iron particles. Similarly, silver colloidal metal particles are proven to be effective in treating skin conditions, such as acne and chickenpox.

They are also effective against various infections. Growing market for dietary supplements, as a whole, is anticipated to have an optimistic impact on the colloidal metal particles market.

However, the issue of toxicity has put forth several legislative barriers in the development of the colloidal metal particles market. Some studies have also shown that uncontrolled use of such particles contaminates the environment and hence, country level regulations have been passed to monitor the consumption of the aforementioned colloidal metal particles, among others.

Global Colloidal Metal Particles Market Segmentation Analysis

The Colloidal Metal Particles market has been categorised on application basis into catalysis & photocatalysis, adsorbent, drug delivery and dietary supplements.

On application basis, the catalysis & photocatalysis segment is forecast to retain leading position in the colloidal metal particles market in terms of both consumption as well as revenue generation
The dietary supplement segment is projected to grow at a robust CAGR during the forecast period. Its market value is expected to grow and become over 2.2X between 2022 and 2028

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-9012

Global Colloidal Metal Particles Market Regional Forecast

Regionally, China alone accounts for a prominent proportion of the global colloidal metal particles market, positioning itself with the likes of multi-country regions, such as North America and Western Europe. Accounting for well over 22% of the revenue proportion in the total colloidal metal particles market, China is anticipated to register significant CAGR during the forecast period.

The overall Colloidal Metal Particles market is expected to grow at a CAGR of 8.1% while regions, such as Western Europe, Eastern Europe, and countries, such as India and Japan, are expected to grow at a moderately higher pace owing to rising demand in these regions.

Global Colloidal Metal Particles Market Competition Landscape

The report highlights some of the top companies operating in the global Colloidal Metal Particles market, including Nouryon BV, Purest Colloids, Inc., Tanaka Holdings Co., Ltd., Evonik Industries AG, IMRA America, Inc, W. R. Grace & Co., SunForce Health & Organics Inc. and BBI Solutions, among others.

Key Segment

Product Type

Aluminium Oxide
Silver
Gold
Zinc
Copper
Platinum
Iridium
Silicon
Iron Oxide
Titanium Oxide
Palladium
Others (manganese, cerium, indium, tin)

Application

Catalysis & Photocatalysis
Adsorbent
Drug Delivery
Dietary Supplements

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-9012

About Future Market Insights (FMI)

Peripheral Vascular Stents Market is expected to expand at CAGR of 6.6% over 2022–2028, to reach US$ 5,324.1 Million by 2028 end

[263 Pages Report] According to the latest market report published by Future Market Insights, titled ‘Peripheral Vascular Stents Market: Global Industry Analysis 2013 – 2021 and Opportunity Assessment 2022 – 2028’, the global peripheral vascular stents market is expected to expand at a CAGR of 6.6% over the forecast period 2022–2028.

peripheral vascular stents market

FMI estimates that the global market for peripheral vascular stents is to be valued at US$ 2,822.5 Mn in 2022 and is expected to expand at CAGR of 6.6% over 2022–2028, to reach US$ 5,324.1 Mn by 2028 end. Based on product type, the self-expanding stents segment dominated the global peripheral vascular stents market, with over 52.1% value share in 2021. The segment is expected to grow at above 6.6% CAGR over the forecast period.North America is expected to maintain its dominance in the global market due to regulatory approval of several new products such as drug eluting stents in the U.S., Europe and Japan. Increasing awareness of peripheral surgeries and prevalence of peripheral artery disease in developing countries such as India and Brazil remains the major factor driving the demand for peripheral vascular stents. Increasing in number end users and growing number of ambulatory surgical centres are the other major factors expected to drive the growth of the global peripheral vascular stents market.

An intravascular stent is a synthetic tubular mesh structure used for permanent implant in graft or native vasculature. A stent is basically designed to provide mechanical radial support after assigning; the support is meant to improve vessel patency over the life of the device. After the stent is placed in the intended location, it is expanded by a balloon or self-expanding mechanism.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2091

Global Peripheral Vascular Stents Market: Segmental Forecast

The global peripheral vascular stents market has been segmented on the basis of product type, artery type, end user and regions. Globally, the self-expanding stents is expected to be the most attractive segment from the manufacturers’ point of view. Although there is a high demand for drug eluting stents and the segment leads in terms of market volume in the forecast period, high price of drug eluting stents would lead to low revenue contribution of the product type segment. Among all the artery types, high demand of peripheral stents is expected to come from iliac artery segment due to growing prevalence for peripheral artery disease in many countries across the globe.

Global Peripheral Vascular Stents Market: Regional Analysis

In terms of value, the global peripheral vascular stents market is expected to expand at 6.6% CAGR over the forecast period of 2022–2028. With nearly 48.5% market share, North America dominated in the global peripheral vascular stents market in 2021, partly due to penetration of newly approved drug eluting stents in the U.S. Western Europe is expected to be the second large market globally, with the U.K., Italy, France and Germany being countries with high growth rates. APEJ is expected to be the second large market for peripheral vascular stents, primarily due to improving immunization access and availability of cost-effective surgeries.

Global Peripheral Vascular Stents Market: Competition Tracking

The market for peripheral vascular stents is consolidated with few players contributing over 55% of revenue share. The key players identified in the global market include Medtronic Plc., Becton, Dickinson and Company, Cardinal Health, Inc., B. Braun Melsungen AG, MicroPort Scientific Corporation, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Abbott Laboratories, W.L. Gore & Associates Inc., and Cook Medical Inc., among others. Acquisition of established products to gain immediate growth is the key strategy adopted by key players in the market.

Key Segments Covered Peripheral Vascular Stents Industry SurveyPeripheral Vascular Stents Market by Product Type

Self-Expanding Stents
Balloon-Expanding Stents
Covered Stents
Drug-Eluting Stents

Peripheral Vascular Stents Market by Artery Type

Carotid Artery
Fem-Pop Artery
Iliac Artery
Infrapop Artery

Peripheral Vascular Stents Market by End User

Hospitals
Ambulatory Surgical Centers/Outpatients

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2091

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Membrane Microfiltration Market suggest that the industry is slated to generate a value of US$ 5,096.5 Million in 2022

[242 Pages Report] Several traditional techniques such as pasteurisation, heat treatment, and sterilisation have long been used to improve the shelf life of milk. One of the newest alternatives to heat treatment is microfiltration that reduces bacteria and improves the shelf life of dairy products, while also preserving the basic taste. Adoption of membrane microfiltration in milk is one of the trends being witnessed in the global market, according to a new research study on the global membrane microfiltration market by Future Market Insights.

Membrane Microfiltration Market Size (2022)	US$ 5,096.5 Mn
Projected Market Value (2028)	US$ 8,048.5 Mn
Global Market Growth Rate (2022-2028)	7.9% CAGR
Region With Dominant Market Share	Western Europe

An increasing adoption of ceramic microfiltration membranes for cross flow filtration in water plants is another key trend, as ceramic membranes help maintain a high filtration rate and ensure enhanced savings in membrane replacement costs.

Manufacturers in the membrane microfiltration market are producing robust microfiltration systems using large filter cartridges that occupy lesser space and eliminate the number of filtration system connections, thereby reducing maintenance costs.

A preference for continuous fermentation over batch processing is also being observed, with manufacturers increasingly deploying membrane microfiltration technology in their plants. These trends are likely to positively impact revenue growth of the global membrane microfiltration market in the coming years.

According to Future Market Insights forecasts, sales revenue in the membrane microfiltration market is anticipated to cross US$ 8 Bn by 2028, from an estimated value of about US$ 3.8 Bn in 2018. A decadal growth rate of 7.8% can be attributed to several factors, of which Future Market Insights throws deeper insights in this research study.

To remain ahead of your competitors, request for a sample -@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5402

membrane microfiltration market

Increasing Applications in Industrial Biotechnology and Widespread Use of Large Molecule Biopharmaceuticals Pushing Revenue Growth of the Global Membrane Microfiltration Market

Membrane microfiltration is finding application in the production of biofuel and bio refineries are incorporating this technology to lower the overall energy costs and reduce industrial bio waste. Membrane microfiltration is also increasingly used in biodiesel processes where this technology is used to reuse water especially in areas of water scarcity. The rising industrial applications of membrane microfiltration are fuelling revenue growth in the global market. Also, filtration is a critical component of biopharmaceuticals production, and membrane microfiltration is widely used to remove cellular debris and other cellular colloids. With a growing adoption of large molecule biopharmaceuticals owing to their therapeutic properties, the demand for membrane microfiltration technology in the production of biopharmaceuticals is expected to surge in the near future.

Membrane microfiltration is also extensively used in the food and beverages industry as a technology to separate and purify components and improve the quality and yield of food products. An increasing use in vegetable and fruit juices, fermented dairy products, milk and dairy products, non-alcoholic beverages, and other food and beverage products is expected to spur revenue growth of the global membrane microfiltration market to a significant extent. One of the other critical application areas of membrane microfiltration is in water treatment plants. Membrane microfiltration helps remove unwanted particles from water before the water is treated for purity using other processes such as reverse osmosis. A growing need for quality potable water is further driving growth of the membrane microfiltration market.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-5402

Key Segments Covered in the Membrane Microfiltration Industry SurveyMembrane Microfiltration by Material Type:

Cross Flow Membranes
- PES Membrane Filters
- PP Membrane Filters
- PVDF Membrane Filters
- PTFE Membrane Filters
- PEEK Membrane Filters
- Poly Imide Membrane Filters
- Cellulose Membrane Filters
Direct Flow Membranes
- PES Membrane Filters
- PP Membrane Filters
- PVDF Membrane Filters
- PTFE Membrane Filters
- PEEK Membrane Filters
- Poly Imide Membrane Filters
- Cellulose Membrane Filters

Membrane Filtration by Application:

Biopharmaceutical Processing
Water Treatment Applications
Dairy & Food Processing
Chemical Applications
Others

Membrane Filtration by Region:

North America Membrane Filtration Market
Latin America Membrane Filtration Market
Europe Membrane Filtration Market
East Asia Membrane Filtration Market
South Asia & Pacific Membrane Filtration Market
Middle East & Africa (MEA) Membrane Filtration Market

Key Questions Answered in the Report

What valuation will the membrane microfiltration market enjoy in 2022?

What is the predicted market worth through 2028, as per the membrane microfiltration market research report?

Which region has a dominant outlook in the global membrane microfiltration landscape?

How is the membrane microfiltration market expected to evolve over the forecast period?

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/5402

Animal Model Market registering a healthy CAGR of 6.6% from 2022 to 2028 and is estimated to reach US$ 2.4 Billion by 2028

[170 Pages Report] According to a recently compiled study by Future Market Insights, the global animal model market will reflect an impressive CAGR through the forecast period, 2017 to 2026. Revenues from the global market for animal model are poised to surpass US$ 2,200 Mn by 2026-end.

animal model market

Leveraging Animal Models offers Better Understanding of Different Diseases

Animals and human beings share a common biological as well as physiological structure. Animals possess shorter life cycle, however they have high genotype resemblance. It is simple and easy to control the animal environment as compared to the human beings.The animal models are increasingly being used in the biomedical research that helps to develop new treatment methods for various diseases. Leveraging animal models offers a better understanding of different diseases, along with the efficacy of drugs with regard to the diseases.

Owing to these factors, demand for animal models has been witnessing a significant surge in the healthcare sector. Alternatives such as cell cultures, tissue cultures, and computer models are also available, however animal models are more preferred owing to the complexity of the living systems. This further makes animal models an effective choice for biomedical research.

Development of animal models, which are more predictive in being effective is an iterative process. However, progress is being made, with researchers applying new experimental approaches to elucidate the biology of specific diseases for the creating of new and efficient animal models.

During the development of new drugs dedicated to complex diseases, researchers are being well advised for testing drugs in multiple animal models as well as in mouse strains with different genetic backgrounds.

Researchers are also focusing on employing translational efficacy or pharmacodynamic biomarkers for linking efficacy observed in clinical results with pre-clinical analyses.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-3141

Key Takeaways from FMI’s Report on Global Animal Model Market

North America is expected to remain the largest and fastest expanding market for animal model, with revenues estimated to surpass US$ 800 Mn by 2026-end. Between animal model markets in Asia-Pacific and Europe, the former will account for relatively larger revenue share, whereas the latter will expand at a comparatively higher CAGR through 2026. Although the market in South Korea will account for the lowest market revenue share, revenues are projected to expand at a relatively higher CAGR than those from the markets in Latin America and Middle East & Africa (MEA) through 2026.
On the basis of species, revenues from rats and mice are projected to account for over two-fifth share of the market by 2026-end. Revenues from use of rats in animal models will expand at the highest CAGR in the market through 2026. In addition, revenues from use of cats and monkeys in animal models will rise at a nearly equal CAGR through 2026. Dogs and pigs are expected to remain the least lucrative species used in animal models during the forecast period.
Contract research organizations (CROs) and biotechnology companies are anticipated to remain the fast expanding end-users of animal models. Revenues from these two end-users are collectively forecast to surpass US$ 850 Mn by 2026-end. In terms of revenues, academic & research institutions and pharmaceutical companies will continue to be dominant end-users in the global animal model market.
Basic and applied research application of animal model will continue to register the fastest expansion through 2026. However, drug discovery/development will remain the most lucrative application of animal model.
Key companies actively contributing to growth of the global animal model market include Transposagen Biopharmaceuticals, Inc., Envigo CRS SA, Crown Bioscience, Inc., Eurofins Scientific SE, Genoway SA, Taconic Biosciences, Inc., Trans Genic Inc, The Jackson Laboratory, Horizon Discovery Group plc, and Charles River Laboratories International, Inc.

Key Segments of Animal Model Industry ResearchAnimal Model Market by Species:

Rats
Mice
Guinea Pigs
Rabbits
Monkeys
Dogs
Pigs
Cats
Other Species

Animal Model Market by End User:

Academic & Research Institutions
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations (CROs)
Other End Users

Animal Model Market by Application:

Basic and Applied Research
Drug Discovery/Development

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-3141

Animal Model Market by Region:

North America Animal Model Market
Latin America Animal Model Market
Europe Animal Model Market
East Asia Animal Model Market
South Asia & Pacific Animal Model Market
Middle East & Africa (MEA) Animal Model Market

Glanzmann Thrombasthenia Market Market Size, Top Key Players, Latest Trends, Regional Insights and Global Industry Dynamics By 2022-2030

lanzmann Thrombasthenia is a rare genetic disorder. It is blood clotting disorder which is characterized by compromised functioning of the specialized blood cells (platelets). Platelets are crucial for proper blood clotting.

Glanzmann Thrombasthenia disorder has normal number of platelets in the blood with abnormal function of the platelets.

The symptoms of glanzmann thrombasthenia include profuse bleeding, especially after any surgical procedure, susceptibility of easy bruising, intermittent gastrointestinal bleeding, bleeding from gums, nose bleeding and purple or red visibly large patches on the skin caused by internal bleeding under the skin.

Request for the Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-12578

Women suffering from glanzmann thrombasthenia may suffer from excessive menstrual bleeding, disproportionate bleeding during childbirth, irregular uterine bleeding. The symptoms of glanzmann thrombasthenia vary greatly from mild bruising to severe haemorrhages making it even life-threatening.

The severity of COVID-19 affecting different population lies in the different genetic build-up of these populations. Scientists all over the world are trying to understand this correlation.

Since, it is a novel virus and not much information is available to the scientific community, it is quite unknown how it can affect the people suffering from rare genetic diseases like glanzmann thrombasthenia.

Glanzmann Thrombasthenia Market: Drivers and Restraints

The major push factors for the global market of glanzmann thrombasthenia treatment are increasing healthcare expenditure by the various governments worldwide coupled with growing awareness in the general public about rare genetic blood clotting disorders.

Another factor could be there is increased number of diagnosed population worldwide suffering from some or the other blood clotting disorder.

The increasing sophistication of healthcare network around the globe in terms of new collaborations between governments of various countries, research institutes and academia will generate a new momentum for the global market of glanzmann thrombasthenia treatment.

However, there are some pull factors also which would act as roadblocks in the development of glanzmann thrombasthenia market. First among them could be high cost of treatment required for rare genetic diseases in general and blood clotting disorders in particular.

Lack of adequate healthcare infrastructure and facilities for early diagnosis and treatment is the other factor which could hamper the growth of global market of glanzmann thrombasthenia treatment.

Lastly, often the diagnosis of glanzmann thrombasthenia go unnoticed, resulting in no treatment, further hindering the market.

Glanzmann Thrombasthenia Market: Overview

Based on drug class, the recombinant activated factor VII segment in the global glanzmann thrombasthenia market seems to register promising growth based on the fact that the treatment is successful in stopping bleeding in almost 90% of the cases of glanzmann thrombasthenia.

Based on the distribution channel, hospital pharmacies segment in the global glanzmann thrombasthenia market is estimated to grow fastest owing to the treatment of rare genetic disease under the guidance of professional medical expert.

Glanzmann Thrombasthenia Market: Region-wise Outlook

The global glanzmann thrombasthenia market will witness a different pattern as compared to other market patterns in terms of region wise dominance. Middle East can be estimated to be the lucrative market for glanzmann thrombasthenia as most cases of glanzmann thrombasthenia are observed in the Middle East region and some particular regions of Europe.

Countries like Iran, Israel, Saudi Arabia, Jordan, Iraq, Palestine have majority of cases owing to the fact of consanguinity being a common feature of these societies. Pockets of Asia, like Southern India have also registered some cases of glanzmann thrombasthenia.

European Countries like France and Romania can be estimated to be other emergent market owing to some incidences of glanzmann thrombasthenia. North America, however, can still be estimated to be an important market for the global glanzmann thrombasthenia market since the pharmaceutical industry there has the skills and resources to spur the growth.

Glanzmann Thrombasthenia Treatment Market: Key Players

The key players functioning the global market for glanzmann thrombasthenia are

Novo Nordisk
Alnylam Pharmaceuticals
Shire (Takeda)
Biogen
Bioverativ (Sanofi)
Bayer
CSL Behring
Grifols
Bristol-Myers Squibb and Pfizer.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.

It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Indication
Value Chain

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Europe (Germany, U.K, France, Italy, Spain)
South Asia (India, ASEAN Countries)
East Asia (Japan, China & South Korea)
Oceania (Australia & New Zealand)
Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.

The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Glanzmann Thrombasthenia Market: Segmentation

The global market of glanzmann thrombasthenia is segmented based on the drug class, route of administration, distribution channel and region.

drug class:

Platelet Transfusion
Recombinant Activated Factor VII
Antifibrinolytics
Fibrin Sealants
Thrombin
Desmopressin

route of administration:

Oral
Topical
Injectable

Request for the complete TOC of this Report: https://www.futuremarketinsights.com/toc/rep-gb-12578

distribution channel

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies

About Future Market Insights (FMI)

Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Neurovascular Guidewires Market size is expected to reach US$ 399.1 Million by the end of 2028.

[269 Pages Report] The global demand for neurovascular guidewires will reach the valuation of nearly US$ 280 million in 2022, witnessing an estimated increase of 3.6% over 2022. Over 2022-2028, the global neurovascular guidewires market revenue is likely to expand 1.5X.

neurovascular guidewires market

According to a new research study of Future Market Insights,

Straight tip guidewires, with a current share of more than a third of the total market value, will retain the dominant position in neurovascular guidewires market through 2028.
Aneurysms and intra-and extra-cranial angioplasty reflect highest applicability of neurovascular guidewires.
Hospitals, though anticipated to reflect limited investment opportunities in the neurovascular guidewire market, will remain the leading end-use segment with the maximum share in terms of revenue generation.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-3121

The Increasing Number of Neurovascular Disease Treatment Alternatives

Neurovascular guidewires, among the latest innovations in the neurovascular disease treatment landscape, has been pushing the number of neurovascular surgeries since introduction. This according to the report will remain a key factor sustaining demand for neurovascular guidewires in the global market over the coming years.

As the advent of technology used in neurovascular surgeries has significantly increased the number of treatment options for neurovascular diseases, the treatment by using neurovascular guidewires is gaining ground rapidly owing to the relatively lower risk associated with surgical treatment, over conventional surgeries. The usage of guidewires is the mainstay for neurovascular therapy, along with new technologies such as coating-based guidewires, which has contributed substantially to the treatment options for complex lesions that are treated surgically.

The increasing number of neurovascular neuroradiology procedures is also boosting the demand for access products, which is another factor driving the neurovascular guidewires market. The number of neurovascular interventions is increasing with growing awareness among surgeons about the cost benefit associated with the neurovascular guidewires. Besides, reimbursement policies for outpatient surgeries are also expected to propel the neurovascular guidewires market revenue. Furthermore, an increase in the number of end users such as ambulatory surgical centers in underdeveloped and developing countries is boosting the number of outpatients cases, which is also expected to drive the overall market for neurovascular guidewires.

Favorable Reimbursement Scenario & Government Support

The growing prevalence and incidence of cerebral infarction, aneurysm, and stroke is projected to fuel the demand for neurovascular guidewires. Growth in the number of patients suffering from ischemic stroke across the world is also estimated to boost the adoption of neurovascular guidewire and contribute to the growth of the global neurovascular guidewire market during the forecast period.

Similarly, increasing incidence of arteriovenous malformations is also contributing to growth in the demand for neurovascular guidewires. The increasing prevalence of intracranial and extracranial angioplasty is another factor that is expected to drive the neurovascular guidewires market.

Neurovascular guidewires are effective and safe devices in neurovascular intervention procedures for patients suffering from neurovascular diseases. Modifications in reimbursement policies are encouraging the number of outpatients in developed countries. Government initiatives and local reimbursement policies pertaining to the usage of neurovascular guidewires are also expected to boost the neurovascular guidewire market over the forecast period.

Rising awareness about cerebral infarction is also estimated to contribute to the growth of the market. The reimbursement policies for the treatment of brain aneurysm are also contributing to the growth of the neurovascular guidewires market as the patients are not required to pay from their own pocket.

FMI’s report tracks some of the key companies operating in the neurovascular guidewire market, which include Boston Scientific Corporation, Medtronic, Penumbra Inc., Stryker, Asahi Intecc Co. Ltd, Integer Holding Corporation, Cordis Corporation, CONMED Corporation, phenox GmbH, and Integer Holding Corporation, among others.

Neurovascular Guidewires Market

by CategoryProduct:

Shapeable Tip Guidewires
Straight Tip Guidewires
Angled Tip Guidewires
Round curve Tip Guidewires

Application:

Arteriovenous Malformations
Intracranial and Extra-Cranial Angioplasty
Aneurysms
Minimally Invasive Spine surgery
Cerebral Angiography

Coating Type:

Hydrophilic Guidewires
Hydrophobic Guidewires

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3121

End User:

Hospitals
Laboratories
Research Institutes
Biopharmaceutical Companies
Others

Implantable Drug-Eluting Devices Market is expected to reach a valuation of around US$ 12.8 Billion as of 2022

[326 Pages Report] Implantable drug-eluting devices are playing a key role in the management and treatment of various chronic disorders, particularly cardiovascular diseases. Advancements in micro and nanotechnology are aiding key manufacturers to design novel implantable drug-eluting devices.

Moreover, controlled and site-specific attributes of implantable drug-eluting devices, further complemented by compatibility with the targeted drug delivery, are relieving the burden of complex dosing schedule and systemic toxicity of conventional drug delivery system. The global implantable drug-eluting devices market is projected to cross the US$ 10 Bn mark towards the end of 2022. Market leaders in implantable drug-eluting devices landscape are maintaining their focus on refining manufacturing processes.

Growth of implantable drug-eluting devices market can be prominently attributed to the associated cost-effective technology and novel medication administration techniques. Fewer side effects while these devices are utilized in the management of chronic diseases as well as in contraception have been the strongest attribute accounting for a steadily expanding market for implantable drug-eluting devices.

implantable drug eluting devices market

Remote-Controlled Chips and Programmable Devices – Future of Targeted Drug Delivery

Increasing clinical trials and research & development of remote-controlled and programmable drug-eluting devices

Massachusetts Institute of Technology (MIT) researchers have developed a remote-controlled contraceptive hormone (levonorgestrel) delivery chip implant, which can turn the device on and off.

Implantable drug-eluting devices allow minimum effective doses and support oral opioid weaning

Implantable drug-eluting devices such as SynchroMed II intrathecal drug delivery system with controlled workflow system, plays an effective role in reducing or eliminate the use of oral opioids.

Antiretroviral (ARV) drug implant is expected to emerge as a promising approach for HIV treatment and prevention

In July 2022, Merck & Co. started the development of slow-release antiretroviral (ARV) drug implant as a promising approach for HIV treatment.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-10671

Know More About Implantable Drug-Eluting Devices Market Report

The implantable drug-eluting devices market, a new study from Future Market Insights, opines on the evolution of the implantable drug-eluting devices market from 2014 – 2021 and presents demand projections from 2022 – 2029 on basis of product type (implantable drug infusion pumps, intraocular drug-eluting devices, contraceptive drug-eluting devices, buprenorphine implant and drug-eluting stents), technology (active drug-eluting devices and passive drug-eluting devices) applications (diabetes macular edema, birth control/contraception, opioid addiction, cardiovascular, ophthalmology, oncology, pain management, others) implantation type (intravaginal, intravascular, intraocular, intrathecal, subcutaneous, intrauterine) end users (hospitals, ambulatory surgical centers, optical care centers, cardiac surgery centers, office-based setting and others) in seven prominent regions.

Medical-Pharma Collaborating to Balance Demand and Supply

A comprehensive view of the implantable drug-eluting devices market has led our analysts to conclude that, the market is expected to grow with an impressive rate. This market growth is mainly attributed due to increasing innovations and developments in implantable drug-eluting devices for the management and treatment of breast cancer, schizophrenia, Parkinson’s disease, and photosensitivity diseases. Besides, FMI analyst suggests that markets in North America and Europe are expected to hold major value shares in global implantable drug-eluting devices landscape. To cater to rising demand for implantable drug-eluting devices, medical device companies are collaborating with pharmaceutical companies for the development of efficient drug delivery devices.

Increasing use of syringe-based subcutaneous implantable drug-eluting devices is anticipated to minimize the number of invasive surgical procedures. Introduction of implantable drug-eluting devices or rare conditions such as central precocious puberty (CPP) will emerge as an important factor shaping the market for implantable drug-eluting devices.

Key Market Segments Covered in Implantable Drug Eluting Devices Industry Research

By Product:

Implantable Drug Infusion Pumps
Intraocular Drug Eluting Devices
Contraceptive Drug Eluting Devices
Buprenorphine Implant
Drug Eluting Stents
Others

By Technology:

Active Drug Eluting Device
Passive Drug Eluting Device
- Biodegradable Implants
- Non-Biodegradable Implants

By Application:

Diabetic Macular Edema
Birth Control/Contraception
Opioid Addiction
Cardiovascular
Ophthalmology
Oncology
Pain Management

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-10671